| ASSOCIATION
BETWEEN TESTICULAR MICROLITHIASIS, TESTICULAR CANCER, CRYPTORCHIDISM AND
HISTORY OF ASCENDING TESTIS STAMATIOU KONSTANTINOS, ALEVIZOS ALEVIZOS, MARIOLIS ANARGIROS, MIHAS CONSTANTINOS, HALAZONITIS ATHANASE, BOVIS KONSTANTINOS, ELEFTHERIOS MICHAIL, SOFRAS FRAGISKOS Department of Urology (SK, BK, EM), Tzaneion General Hospital, Athens, Greece, Urban Health Center of Vyronas (AA, MA, MC, HA), Athens, Greece, and Department of Urology (SF), School of Medicine, University of Crete, Heraklion, Greece ABSTRACT Objective:
To prospectively determine the prevalence of testicular microlithiasis
in symptomatic patients who were referred for scrotal ultrasound examination
and to evaluate the possible association of testicular microlithiasis
with testicular cancer and other conditions such as cryptorchidism or
history of ascending testis. Key
words: testis; lithiasis; ultrasound; cryptorchidism; testicular
neoplasms INTRODUCTION Testicular microlithiasis is a relatively uncommon condition characterized by calcifications within the testicular parenchyma visible through ultrasonographic imaging, which was firstly reported by Priebe & Garret in the early 70’s (1). Disseminated microcalcifications in various numbers, can be found inside the seminiferous tubules of the testicular parenchyma in less than 9% of symptomatic patients referred for scrotal ultrasonography (2-5), however, this incidence seems to increase with the use of high-frequency ultrasound devices (6). The clinical importance of entities such as testicular microlithiasis (in terms of symptoms and potential malignancy), is not well documented. Microcalcifications themselves are not malignant but they have been found in testes, in association with germ cell tumors in variable proportions. In the last few years, testicular microcalcifications have been considered an imaging marker of testicular cancer, with several authors recommending a serial scrotal ultrasound screening in patients with testicular microlithiasis, in order to detect possible testicular tumors in asymptomatic patients (7). Although some reports have indicated a prevalence of testicular microlithiasis in asymptomatic men referred for testicular ultrasound between 0.6% - 0.7% (8-10), the actual prevalence of testicular microlithiasis in the general population is unknown. The aim of our study was to determine the prevalence of testicular microlithiasis in symptomatic patients who were referred for scrotal ultrasound examination and to evaluate the association of testicular microlithiasis with testicular cancer and other non-malignant conditions. MATERIALS AND METHODS Patients in this study included 468 men who were referred to our institution between July 2002 and May 2005 for any type of symptoms from the testicles (feeling of weight, pain, painful or painless inflammation, etc). All were aged between 15 and 76 years (median age 45.5 mean age 37) and all were from Athens and nearby suburbs. Men were eligible for enrollment if they never had a previous diagnosis of testis cancer, previous scrotal infection or history of testis surgery, with the exception of surgery cases regarding cryptorchidism. Of the 77 patients who were excluded from the study, 52 had a history of previous scrotal infection, while the remaining 15 had a history of testis surgery. All patients underwent physical and laboratory examination and were subjected to a scrotal ultrasound examination which was performed by 2 expert radiologists (HA, MC). Ultrasonographic criteria for the diagnosis of testicular microlithiasis were the presence of at least 5 pinpoint hyperechoic foci of size smaller than 3 mm in one field of view without posterior shadowing (11). The presence of testicular microlithiasis, the number of lesions and the involvement of both testicles in relation to the symptoms and the coexistence of other lesions were studied. Patients found with testicular microlithiasis were further investigated with biochemical tumor markers, chess x ray and if necessary with abdominal and pelvic computed tomography (CT) and placed in bi-annual follow-up with physical examination and scrotal ultrasound. All patients underwent the appropriate therapy. The association of pathologically confirmed testicular microlithiasis and testicular cancer were assessed with statistical analyses. A p value less than 0.05 was considered to indicate a statistically significant difference. RESULTS Of
the 468 patients eligible, 391 fulfilled the inclusion criteria and were
finally enrolled in the study. Eighteen (4.6%) out of 391 men who enrolled
in the study had testicular microlithiasis (Figure-1). According to the
data obtained from the medical history of each participant, thirty six
men reported having a history of ascending testis, while two of them were
diagnosed in our institutions with torsioned testis in a cryptorchid abdominal
position (probably ascending testis), in which the orchidectomy specimen
(after surgery) was negative for testicular cancer. None of the three
cases with testis surgery in early childhood for cryptorchidism had testicular
microlithiasis. Testicular microlithiasis was the only finding in 10 patients,
three patients had a concomitant varicocele, while both cases of torsioned
cryptorchid testis had testicular microlithiasis in orchidectomy specimen.
From 12 patients diagnosed with spermatic cord torsion only one had testicular
microlithiasis in orchidectomy specimen. From the remaining patients 149
had epididymitis, 78 patients had varicocele, 24 patients had blunt trauma
on left or right testis, 17 had hernia, 14 spermatocele, 13 had an urinary
stone in the lower third of the left or right ureter, and 11 patients
had periorchitis clinically diagnosed and confirmed with both laboratory
and echographic examination. None of them had microcalcifications (in
terms of testicular microlithiasis) in his scrotum ultrasound. Despite
the extensive investigation, no evident cause for the symptoms was obtained
for 51 men, and they have been dismissed from the urologic department
without a urology-related diagnosis. Seven patients had testicular cancer
diagnosed with both biochemical tumor markers and echographic examination
and also confirmed by pathologic examination. All cases of testicular
cancer were germ cell tumors. Two of them had coexistent testicular microliths
(11.1%) in the orchidectomy specimen, evidenced in the pathologic examination
as hematoxylin bodies. Interestingly the number of calcifications in these
cases was relatively higher than that obtained from normal testes. Only
five of the 373 (1.3%) patients without microlithiasis were found with
an overt testicular cancer. One year after the initiation of follow up,
in one of the patients with testicular microlithiasis a rise in testicular
tumor markers (LDH, and HCG) was encountered and orchidectomy was performed. COMMENTS Since the first detailed description of this ultrasonographic entity (12) the biological meaning remains unclear. Whether and if testicular microlithiasis is present before the development of testicular germ cell tumors and the time needed to develop testicular cancer is not well known thus the prognostic value of this entity as a precancerous lesion for testicular cancer remains controversial (13). Although several authors suggested that testicular microlithiasis should be considered a premalignant condition, wide variation in the reported incidence of testicular microlithiasis in men with concomitant germ cell malignancy (6-75%) indicates that probably it is not the case (1,14-16). Other studies have showed that bilateral microlithiasis has been associated to the pre-invasive stage of germ cells testicular cancer more than unilateral (17,18), but this finding could be the effect of bias since testicular microlithiasis usually occurs bilaterally (2,19). On the other hand, testicular microlithiasis is found more often in men with concomitant benign testicular conditions [cryptorchidism, testicular dysgenesis, male infertility, testicular torsion and atrophy, Klinefelter’s syndrome, hypogonadism, male pseudohermaphroditism, varicocele, and epididymal cysts (20-22)] proposing that the microcalcifications themselves are not malignant. Indeed, ultrasonic microliths may be visible for many reasons, for example histological microliths, hyalinased tubules, carcinoma in situ, or for unknown reasons (23) and thus are heterogeneous. Pathologically, 2 types of calcifications have been described (24): hematoxylin bodies consisting of amorphous calcific debris and laminated calcifications consisting of cellular debris and glucoprotein accumulation.: while hematoxylin bodies are not seen in the absence of germ cell neoplasia and are considered specific for germ cell tumors, laminated calcifications which are even more common in germ cell tumors also occur in otherwise normal testis. The pathogenesis of laminated microcalcifications is probably due to dysgenesis of the testis, with slough of degenerated cells inside an obstructed seminiferous tubule and failure of the Sertoli cells to phagocytize the debris. Secondarily, calcification occurs. This may explain why microlithiasis is found to accompany both germ cell tumors and non-malignant conditions connected to infertility. Ultrasonic microliths coexistent with germ cell tumors were histologically found to be hematoxylin bodies. In our study group, the incidence of testicular microlithiasis (4.6%) and the percentage of patients with testicular cancer among testicular microlithiasis patients (11%), were in accordance with most of the aforementioned studies (0.6-9% and 6-75% respectively). In addition, our finding of rapid onset of testis cancer (within 15 months) in a patient with known testicular microlithiasis, is in agreement with several authors (19), although in other studies testicular cancer has been developed even seven years after the primary diagnosis of testicular microlithiasis (25). Furthermore, since in our study testicular microlithiasis was not associated with any individual symptom or any non-malignant condition from the testis, we believe that the detection of testicular microlithiasis can probably be attributed to chance. In conclusion, we hope that our study adds more evidence in the association between testicular microlithiasis and testicular cancer. Moreover, although it is not known whether and when a patient with testicular microlithiasis would ever develop testicular cancer, we totally agree with the current recommendations and similarly suggest that patients with evidence of testicular microlithiasis should be screened for testicular cancer in a regular basis. CONFLICT OF INTEREST None declared. REFERENCES
____________________ _______________________ The
answer to the question “Should testicular microlithiasis be regarded
as a precursor of testicular cancer?” is still unclear. Actually,
the most important information obtained from this prospective study is
the onset of testis cancer during follow-up of a patient wit testicular
microlithiasis. In the literature so far, there are only 13 reports related
to 15 patients with testicular microlithiasis who subsequently had testicular
cancer. Three of these 13 reports were retrospective studies. Derogee
et al. followed 31 patients with testicular microlithiasis from 16 to
105 months and a combined teratoma and seminoma developed in one patient.
Otite et al. followed 38 patients with testicular microlithiasis and two
of these patients under surveillance developed a testicular malignancy
in which one patient had an atrophic left testis and left testicular tumor
developed. von Eckardstein followed 14 men with testicular microlithiasis
for 24 to 60 months and testicular tumors developed in two of them. Review
of the literature reveals that 4 of the 15 patients had a history of contralateral
testicular tumor. Three patients had also an infertility problem. The
remaining 7 patients with testicular microlithiasis had no associated
abnormality that could be related to tumor development.
|